Iron as a therapeutic target for Parkinson's disease
Caroline Moreau(Hôpital Européen Georges-Pompidou), Z. Ioav Cabantchik(Hebrew University of Jerusalem), David T. Dexter(Cure Parkinson's Trust), Ashley I. Bush(Florey Institute of Neuroscience and Mental Health), Olivier Rascol(Inserm), David Devos(Université de Lille), James A. Duce(Innovate UK), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Jean‐Christophe Devedjian(Inserm)
Cited by 126
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
|Nature Genetics|1993|1.4k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k